Sartorius (OTCMKTS:SARTF) Shares Shorted: Short Interest Down 54.2% in October

Sartorius (OTCMKTS:SARTF – Get Free Report) was the target of a large decline in short interest in October. As of October 30th, there was short interest totaling 836 shares, a decline of 54.2% from the October 15th total of 1,827 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days. Currently, 0.0% of the company’s stock are sold short.

Sartorius Stock Performance

Shares of SARTF stock opened at $261.99 on Tuesday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The company has a market capitalization of $8.97 billion, a P/E ratio of 121.85 and a beta of 0.98. The company’s 50 day moving average price is $242.59 and its two-hundred day moving average price is $224.22. Sartorius has a 52 week low of $181.58 and a 52 week high of $261.99.

Sartorius Company Profile

(Get Free Report)

Sartorius is a life science company headquartered in Göttingen, Germany. Founded in 1870 as a precision-balance manufacturer, it has grown into a global supplier of technologies and services for biopharmaceutical production and laboratory research. The company’s bioprocessing products include filtration and fluid-management systems, single-use equipment, bioreactors, and technologies used in cell culture and purification. These solutions support the development and manufacture of biologic medicines, including vaccines and other advanced therapies.

Further Reading

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.